Skip to main content

The p38 protein regulates the development of new blood vessels in tumours

25 Jul 19




Press and Communications Officer
Tel.+34 93 40 37255

RAC1La Sexta and the newspapers La Vanguardia and ABC, among other media, have echoed on news of a study done by researchers of IRB Barcelona that has demonstrated that the p38 protein regulates the formation of new blood vessels in tumours. A greater understanding of how the development of new blood vessels is regulated may help to improve chemotherapy treatments for cancer. 

Link to RAC1 

Link to La Sexta

Link to La Vanguardia

Link to ABC 

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).